Evaluation of TNF-α and IL-6 Release in the Ventroposterolateral Nucleus of the Thalamus during Central Neuropathic Pain Induced by Electrical Injury of the Spinothalamic Tract in Male Rats: A Microdialysis Study

Authors
A. Ghanbari 1
A. R. Asgari 2
G. R. Kaka 1
H. R. Falahat Pishe 3
A. Naderi 4
M. Jorjani 5
1 Applied Neuroscience Research Center, Baqiyatallah (a.c) University of Medical Sciences, Tehran, Iran
2 Faculty of Aerospace and Subaquatic Medicine, AJA Medical Sciences University, Tehran, Iran
3 Biopharmacy Pars Research Company, Tehran, Iran
4 Department of physiology, Faculty of Medicine, Baqiyatallah (a.c) University of Medical Sciences, Tehran, Iran
5 Department of Pharmacology and Neuroscience Research Center, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Objective: Inflammation and proinflammatory cytokines play an important role in the initiation and maintenance of central neuropathic pain. There are several reports that cytokine production is increased at the lesion site following spinal injury. A few studies have investigated the supraspinal levels of these cytokines. This study intended to determine TNF-α and IL-6 release in the ventroposterolateral nucleus of the thalamus in spinal cord injury-related neuropathic pain in rats. Methods: Male Sprague-Dawley rats that weighed 200-230 g were used. Following administration of anesthesia, spinothalamic tract injury was performed by a laminectomy at the T9-T10 level in male rats. Mechanical allodynia and motor performance were evaluated at 3, 7, 14, 21 and 28 days after spinal injury by Von Frey filament and the open field test, respectively, in the sham and lesion groups. Concentrations of TNF-α and IL-6 in the VPL microdialysate were detected by ELISA in both spinal cord injured and sham groups during four weeks after surgery. Results: Mechanical pain threshold reduced in both hind paws following lateral spinothalamic tract injury. Paw withdrawal threshold in the Spinothalamic tract-injured group was significantly (P<0.05) lower than in sham group at day 14 post-surgery. Motor performance did not show any significant change after surgery. In the microdialysate, TNF-α reduced significantly (P<0.05) at days 3 and 7 post-injury compared to the sham group which returned to a level close to the pre-surgery level. VPL concentration of IL-6 increased significantly (P<0.05) at day 21 post-injury compared to the sham group. Conclusion: Lesions in spinal pathways that contain afferent pain fibers appear to change the supraspinal levels of inflammatory mediators, including VPL, concentrations of TNF-α and IL-6 which are consistent with spinal injury related pain behavior. Cytokine production results in hyperexcitability of the thalamocortical neurons, a decrease in pain threshold, and persistent neuropathic pain after spinal injury.

Keywords

[1]    Beric A. Spinal cord injury pain. Eur J Pain 2003; 7(4): 335-8.
[2]    Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70(18): 1630-5.
[3]    Tasker RR, Dostrovsky JO, Dolan EJ. Computerized tomography (CT) is just as accurate as ventriculography for functional stereotactic thalamotomy. Stereotact Funct Neurosurg 1991; 57(4): 157-66.
[4]    Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136(3): 380-7.
[5]    Toth C, Lander J, Wiebe S. The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med 2009; 10(5): 918-29.
[6]    Hulsebosch CE, Hains BC, Crown ED, Carlton SM. Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res Rev 2009; 60(1): 202-13.
[7]    Gwak YS, Hains BC, Johnson KM, Hulsebosch CE. Effect of age at time of spinal cord injury on behavioral outcomes in rat. J Neurotrauma 2004; 21(8): 983-93.
[8]    Harden N, Cohen M. Unmet needs in the management of neuropathic pain. J Pain Symptom Manage 2003; 25(5 Suppl): S12-7.
[9]    Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005; 257(2): 139-55.
[10] Hulsebosch CE. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp Neurol 2008; 214(1): 6-9.
[11] Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil 2007; 88(11): 1384-93.
[12] Jancálek R, Dubový P, Svízenská I, Klusáková I. Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J Neuroinflammation 2010; 7: 11.
[13] Zelenka M, Schäfers M, Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005; 116(3): 257-63.
[14] McMahon SB, Cafferty WB, Marchand F. Immune and glial cell factors as pain mediators and modulators. Exp Neurol 2005; 192(2): 444-62.
[15] Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005; 28(2): 101-7.
[16] Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excito-toxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001; 21(8): 2580-8.
[17] Hains BC, Waxman SG. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006; 26(16): 4308-17.
[18] Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG, Basso DM. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol 2008; 212(2): 337-47.
[19] Gwak YS, Hulsebosch CE. Gliopathy” Maintains Persistent Hyperexcitability of Spinal Dorsal Horn Neurons after Spinal Cord Injury: Substrate of Central Neuropathic Pain. In: Costa A, Villalba E (Editors). Horizons in Neuroscience Research. New York: Nova Science Publishers, 2010; p:195-224.
[20] Naseri K, Saghaei E, Abbaszadeh F, Afhami M, Haeri A, Rahimi F, Jorjani M. Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats. J Mol Neurosci 2013; 49(3): 470-9.
[21] Horn TF, Engelmann M. In vivo microdialysis for nonapeptides in rat brain--a practical guide. Methods 2001; 23(1): 41-53.
[22] Ungerstedt U. Microdialysis--principles and applications for studies in animals and man. J Intern Med 1991; 230(4): 365-73.
[23] Ao X, Stenken JA. Microdialysis sampling of cytokines. Methods 2006; 38(4): 331-41.
[24] Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 5th ed, San Diego: Elsevier Academic Press, 2005; p; 94.
[25] Saghaei E, Abbaszadeh F, Naseri K, Ghorbanpoor S, Afhami M, Haeri A, Rahimi F, Jorjani M. Estradiol attenuates spinal cord injury-induced pain by suppressing microglial activation in thalamic VPL nuclei of rats. Neurosci Res 2013; 75(4): 316-23.
[26] Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Behav 1999; 67(5): 711-6.
[27] Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82 (4): 981-1011.
[28] Wang G, Thompson SM. Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions. J Neurosci 2008; 28(46): 11959-69.
[29] Wei F, Guo W, Zou S, Ren K, Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 2008; 28(42): 10482-95.
[30] Sacerdote P1, Franchi S, Trovato AE, Valsecchi AE, Panerai AE, Colleoni M. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci Lett 2008; 436(2): 210-3.
[31] Kato K, Kikuchi S, Shubayev VI, Myers RR. Distribution and tumor necrosis factor-alpha isoform binding specificity of locally administered etanercept into injured and uninjured rat sciatic nerve. Neuroscience 2009; 160(2): 492-500.
[32] George A, Buehl A, Sommer C. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol 2005; 192(1): 163-6.
[33] Lee HL, Lee KM, Son SJ, Hwang SH, Cho HJ. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 2004; 15(18): 2807-11.
[34] Li J, Xie W, Zhang JM, Baccei ML. Peripheral nerve injury sensitizes neonatal dorsal horn neurons to tumor necrosis factor-alpha. Mol Pain 2009; 5: 10.
[35] Iwatsuki K, Arai T, Ota H, Kato S, Natsume T, Kurimoto S, Yamamoto M, Hirata H. Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain. PLoS One 2013; 8(2): e57721.
[36] Zhuo M. Neuronal mechanism for neuropathic pain. Mol Pain 2007: 3: 14.
[37] Shubayev VI, Myers RR. Anterograde TNF alpha transport from rat dorsal root ganglion to spinal cord and injured sciatic nerve. Neurosci Lett 2002; 320(1-2): 99-101.
[38] Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 1997; 79(2): 163-75.
[39] DeLeo JA, Colburn RW, Rickman AJ. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 1997; 759(1): 50-7.
[40] Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, White FA. Chemokines and pain mechanisms. Brain Res Rev 2009; 60(1): 125-34.
[41] Zhang YH, Lin JX, Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol 1990; 10(7): 3818-23.
[42] Inoue K, Tsuda M. Microglia and neuropathic pain. Glia 2009; 57(14): 1469-79.
[43] Willis WDJ. Hyperalgesia and Allodynia. New York: Raven Press, 1992.
[44]  Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28(20): 5189-94.
Pathobiology Reserach
Volume 16, Issue 4
February 2014
Pages 83-97